
Profound Medical Corp. PROF
$ 6.81
-1.3%
Quarterly report 2026-Q1
added 05-07-2026
Profound Medical Corp. Cash Conversion Cycle 2011-2026 | PROF
Annual Cash Conversion Cycle Profound Medical Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 594 | 776 | 572 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 776 | 572 | 648 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | ||
|
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
266 | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | ||
|
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M | ||
|
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | ||
|
ClearPoint Neuro
CLPT
|
217 | $ 12.67 | 3.51 % | $ 359 M | ||
|
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
240 | $ 7.75 | -1.77 % | $ 1.16 B | ||
|
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | ||
|
EDAP TMS S.A.
EDAP
|
151 | $ 4.32 | 2.86 % | $ 162 M | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | ||
|
Conformis
CFMS
|
165 | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
40 | $ 1.05 | 1.94 % | $ 17.8 M | ||
|
Helius Medical Technologies
HSDT
|
-219 | $ 1.91 | -6.62 % | $ 42.1 M | ||
|
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | ||
|
Cytosorbents Corporation
CTSO
|
104 | $ 0.49 | -0.99 % | $ 30.5 M | ||
|
OrthoPediatrics Corp.
KIDS
|
714 | $ 17.17 | -3.59 % | $ 403 M | ||
|
LENSAR
LNSR
|
85.4 | $ 5.8 | -3.33 % | $ 69.4 M | ||
|
Delcath Systems
DCTH
|
258 | $ 10.78 | -1.55 % | $ 386 M | ||
|
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | ||
|
Pulmonx Corporation
LUNG
|
246 | $ 1.65 | -1.79 % | $ 67.1 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | ||
|
LivaNova PLC
LIVN
|
113 | $ 73.8 | 1.04 % | $ 4.03 B | ||
|
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
81.2 | - | - | $ 111 M | ||
|
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | ||
|
Myomo
MYO
|
82.3 | $ 1.09 | - | $ 45.6 M | ||
|
MiMedx Group
MDXG
|
125 | $ 3.68 | 0.27 % | $ 544 M | ||
|
Electromed
ELMD
|
180 | $ 37.72 | -4.0 % | $ 319 M | ||
|
Orthofix Medical
OFIX
|
241 | $ 9.27 | -2.32 % | $ 367 M | ||
|
Butterfly Network
BFLY
|
520 | $ 4.55 | -1.3 % | $ 1.12 B | ||
|
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | ||
|
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
314 | $ 81.88 | -0.69 % | $ 11.1 B | ||
|
Insulet Corporation
PODD
|
187 | $ 144.94 | 1.61 % | $ 10.2 B | ||
|
Sintx Technologies
SINT
|
279 | $ 2.24 | 1.82 % | $ 6.21 M | ||
|
CONMED Corporation
CNMD
|
212 | $ 35.7 | 0.51 % | $ 1.11 B | ||
|
Inspire Medical Systems
INSP
|
248 | $ 41.36 | -3.97 % | $ 1.21 B | ||
|
Integer Holdings Corporation
ITGR
|
96.8 | $ 89.38 | -0.74 % | $ 3.1 B | ||
|
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
283 | $ 86.47 | 0.59 % | $ 50.6 B | ||
|
TransMedics Group
TMDX
|
111 | $ 67.2 | -0.93 % | $ 2.28 B |